An in silico method to assess antibody fragment polyreactivity
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Antibodies are essential biological research tools and important therapeutic agents, but some exhibit non-specific binding to off-target proteins and other biomolecules. Such polyreactive antibodies compromise screening pipelines, lead to incorrect and irreproducible experimental results, and are generally intractable for clinical development. Here, we design a set of experiments using a diverse naïve synthetic camelid antibody fragment (nanobody) library to enable machine learning models to accurately assess polyreactivity from protein sequence (AUC > 0.8). Moreover, our models provide quantitative scoring metrics that predict the effect of amino acid substitutions on polyreactivity. We experimentally test our models’ performance on three independent nanobody scaffolds, where over 90% of predicted substitutions successfully reduced polyreactivity. Importantly, the models allow us to diminish the polyreactivity of an angiotensin II type I receptor antagonist nanobody, without compromising its functional properties. We provide a companion web-server that offers a straightforward means of predicting polyreactivity and polyreactivity-reducing mutations for any given nanobody sequence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reproducibility crisis: Blame it on the antibodies
Baker, M. (2015) · Nature · doi:10.1038/521274a · Cited by 830
The therapeutic potential of nanobodies
Jovčevska, I., & Muyldermans, S. (2020) · BioDrugs · doi:10.1007/s40259-019-00392-z · Cited by 749
Reproducibility: Standardize antibodies used in research
Bradbury, A., & Plückthun, A. (2015) · Nature · doi:10.1038/518027a · Cited by 647
Biophysical properties of the clinical-stage antibody landscape
Jain, T., Sun, T., Durand, S., Hall, A., Houston, N. R., Nett, J. H., Sharkey, B., Bobrowicz, B., Caffry, I., Yu, Y., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616408114 · Cited by 629 · cited 4×
“Consistent with previous literature 22,30 , we found that hydrophobicity, as described by thehydrophobicity index 45 , is not strongly predictive of polyreactivity (AUC=0.57, Fig.”
BackgroundMethodInfluentialDesign of protein-binding proteins from the target structure alone
Cao, L., Coventry, B., Goreshnik, I., Huang, B., Sheffler, W., Park, J. S., Jude, K. M., Marković, I., Kadam, R. U., Verschueren, K. H. G., et al. (2022) · Nature · doi:10.1038/s41586-022-04654-9 · Cited by 577
A strategy for risk mitigation of antibodies with fast clearance
Hötzel, I., Theil, F.-P., Bernstein, L. J., Prabhu, S., Deng, R., Quintana, L., Lutman, J., Sibia, R., Chan, P., Bumbaca, D., et al. (2012) · mAbs · doi:10.4161/mabs.22189 · Cited by 245
Birtalan, S., Zhang, Y., Fellouse, F. A., Shao, L., Schaefer, G., & Sidhu, S. S. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.093 · Cited by 244
Bumbaca Yadav, D., Sharma, V. K., Boswell, C. A., Hotzel, I., Tesar, D., Shang, Y., Ying, Y., Fischer, S. K., Grogan, J. L., Chiang, E. Y., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.692434 · Cited by 82
Cited by
Machine learning for functional protein design
Notin, P., Rollins, N., Gal, Y., Sander, C., & Marks, D. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02127-0 · Cited by 270
Self-citationContinuous evolution of user-defined genes at 1 million times the genomic mutation rate
Rix, G., Williams, R. L., Hu, V. J., Spinner, A., Pisera, A. (., Marks, D. S., & Liu, C. C. (2024) · Science · doi:10.1126/science.adm9073 · Cited by 71
Self-citationBashour, H., Smorodina, E., Pariset, M., Zhong, J., Akbar, R., Chernigovskaya, M., Lê Quý, K., Snapkow, I., Rawat, P., Krawczyk, K., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06561-3 · Cited by 32
In silico discovery of nanobody binders to a G-protein coupled receptor using AlphaFold-Multimer
Harvey, E. P., Smith, J. S., Hurley, J. D., Granados, A. J., Schmid, E. W., Liang-Lin, J. G., Zhang, H., Meara, E. M., Wren, E. K., Paul, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-72093-5 · Cited by 7
“However, these methods require specialized equipment and techniques and often generate polyreactive binders due to the lack of in vivo immune fi ltering 7 .”
Self-citationLearning antibody sequence constraints from allelic inclusion
Jagota, M., Hsu, C., Mazumder, T., Sung, K., DeWitt, W. S., Listgarten, J., Matsen, F. A., Ye, C. J., & Song, Y. S. (2024) · doi:10.1101/2024.10.22.619760 · Cited by 2
Metadata
- Authors
- Harvey, E. P., Shin, J.-E., Skiba, M. A., Nemeth, G. R., Hurley, J. D., Wellner, A., Shaw, A. Y., Miranda, V. G., Min, J. K., Liu, C. C., Marks, D. S., & Kruse, A. C.
- Venue
- Nature Communications
- Published
- 2022-12-07
- Volume
- 13
- Issue
- 1
- Pages
- 7554-7554
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W4311168514
- Cited by
- 56
- References
- 8
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An in silico method to assess antibody fragment polyreactivity. https://app.cochat.ai/papers/10.1038/s41467-022-35276-4
- The paper
- Harvey, E. P., Shin, J.-E., Skiba, M. A., Nemeth, G. R., Hurley, J. D., Wellner, A., Shaw, A. Y., Miranda, V. G., Min, J. K., Liu, C. C., Marks, D. S., & Kruse, A. C. (2022). An in silico method to assess antibody fragment polyreactivity. Nature Communications. https://doi.org/10.1038/s41467-022-35276-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.